Last month we discussed hypofractionated treatment effects (HyTEC) including a need for new techniques to minimize toxicities. One of the most common...
Category - Head & Neck Cancer
For the November journal club we will discuss a phase II trial of chemoradiation de-escalation for oropharyngeal cancer. Human papillomavirus (HPV)...
Last month we discussed RTOG 0617, in which one of the randomization added cetuximab to standard chemotherapy for concurrent chemoradiation. The...
The January 2015 #RadOnc journal club will be discussing the article: Institutional clinical trial accrual volume and survival of patients...